| Product NDC: | 10157-9539 |
| Proprietary Name: | Blistex |
| Non Proprietary Name: | Lanolin, Octinoxate, and Oxybenzone |
| Active Ingredient(s): | 13; 7.5; 2.5 g/100g; g/100g; g/100g & nbsp; Lanolin, Octinoxate, and Oxybenzone |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | PASTE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 10157-9539 |
| Labeler Name: | Blistex Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part352 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20110701 |
| Package NDC: | 10157-9539-1 |
| Package Description: | 1 JAR in 1 BLISTER PACK (10157-9539-1) > 7 g in 1 JAR |
| NDC Code | 10157-9539-1 |
| Proprietary Name | Blistex |
| Package Description | 1 JAR in 1 BLISTER PACK (10157-9539-1) > 7 g in 1 JAR |
| Product NDC | 10157-9539 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Lanolin, Octinoxate, and Oxybenzone |
| Dosage Form Name | PASTE |
| Route Name | TOPICAL |
| Start Marketing Date | 20110701 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Blistex Inc. |
| Substance Name | LANOLIN; OCTINOXATE; OXYBENZONE |
| Strength Number | 13; 7.5; 2.5 |
| Strength Unit | g/100g; g/100g; g/100g |
| Pharmaceutical Classes |